Related references
Note: Only part of the references are listed.Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use
Jelle O. Barentsz et al.
EUROPEAN UROLOGY (2016)
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2
Jeffrey C. Weinreb et al.
EUROPEAN UROLOGY (2016)
Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation
V. Panebianco et al.
INSIGHTS INTO IMAGING (2015)
Radiologist, Be Aware: Ten Pitfalls That Confound the Interpretation of Multiparametric Prostate MRI
Andrew B. Rosenkrantz et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2014)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H. Schroder et al.
LANCET (2014)
Metastases in Normal-sized Pelvic Lymph Nodes: Detection with Diffusion-weighted MR Imaging
Harriet C. Thoeny et al.
RADIOLOGY (2014)
New prospects for PET in prostate cancer imaging: a physicist's viewpoint
Maurizio Conti
EJNMMI PHYSICS (2014)
MRI-ultrasound fusion for guidance of targeted prostate biopsy
Leonard Marks et al.
CURRENT OPINION IN UROLOGY (2013)
ESUR prostate MR guidelines 2012
Jelle O. Barentsz et al.
EUROPEAN RADIOLOGY (2012)
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
Gerald L. Andriole et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
The Contemporary Concept of Significant Versus Insignificant Prostate Cancer
Guillaume Ploussard et al.
EUROPEAN UROLOGY (2011)
Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance
Arnauld Villers et al.
CURRENT OPINION IN UROLOGY (2009)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
